Praxis Precision Medicines (PRAX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Praxis Precision Medicines Revenue Highlights


Latest Revenue (Y)

$2.45M

Latest Revenue (Q)

$357.00K

Main Segment (Y)

License

Praxis Precision Medicines Revenue by Period


Praxis Precision Medicines Revenue by Year

DateRevenueChange
2023-12-31$2.45M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Praxis Precision Medicines generated $2.45M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Praxis Precision Medicines Revenue by Quarter

DateRevenueChange
2024-06-30$357.00K-17.17%
2024-03-31$431.00K-16.31%
2023-12-31$515.00K10.04%
2023-09-30$468.00K-40.08%
2023-06-30$781.00K14.35%
2023-03-31$683.00K100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Praxis Precision Medicines generated $357.00K in revenue during Q2 2024, up -17.17% compared to the previous quarter, and up 52.27% compared to the same period a year ago.

Praxis Precision Medicines Revenue Breakdown


Praxis Precision Medicines Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
License$2.40M$98.50M

Praxis Precision Medicines's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23
License$400.00K$400.00K$400.00K$500.00K$800.00K$700.00K

Praxis Precision Medicines's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: License (100.00%).

Praxis Precision Medicines Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
RVMDRevolution Medicines, Inc. Warrant$11.58M-
STOKStoke Therapeutics$8.78M$4.22M
MOLNMolecular Partners$7.04M$2.74M
CRNXCrinetics Pharmaceuticals$4.01M$640.00K
HCWBHCW Biologics$2.84M$618.85K
PRAXPraxis Precision Medicines$2.45M$357.00K
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
IMRXImmuneering--
ANTXAN2 Therapeutics--
PHVSPharvaris--
DYNDyne Therapeutics--
ELYMEliem Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
ELVNEnliven Therapeutics--
EWTXEdgewise Therapeutics--
PEPGPepGen--

PRAX Revenue FAQ


Praxis Precision Medicines's yearly revenue for 2023 was $2.45M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. PRAX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Praxis Precision Medicines's quarterly revenue for Q2 2024 was $357K, a -17.17% decrease from the previous quarter (Q1 2024), and a -54.29% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $431K, a -16.31% decrease from the previous quarter (Q4 2023), and a -36.90% decrease year-over-year (Q1 2023). PRAX's quarterly revenue for Q4 2023 was $515K, a 10.04% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

Praxis Precision Medicines's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

Praxis Precision Medicines's revenue streams in c 23 are License

For the fiscal year ending Dec 23, the largest source of revenue of Praxis Precision Medicines was License. This segment made a revenue of $2.4M, representing 100.00% of the company's total revenue.